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In recent decades, fungal infections have emerged as an important health problem
associated with more people who present deficiencies in the immune system, such
as HIV or transplanted patients. Saccharomyces cerevisiae is one of the emerging
fungal pathogens with a unique characteristic: its presence in many food products.
S. cerevisiae has an impeccably good food safety record compared to other
microorganisms like virus, bacteria and some filamentous fungi. However, humans
unknowingly and inadvertently ingest large viable populations of S. cerevisiae (home-
brewed beer or dietary supplements that contain yeast). In the last few years,
researchers have studied the nature of S. cerevisiae strains and the molecular
mechanisms related to infections. Here we review the last advance made in this
emerging pathogen and we discuss the implication of using this species in food
products.
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INTRODUCTION
Fungal infections are an extremely important health problem. According to numerous studies,
Candida albicans and other Candida species are the most remarkable pathogenic fungi which
cause some 7000-28000 nosocomial infections annually (Pfaller and Diekema, 2007). The general
characteristic of fungal infection is that it is produced as a result of reduced immunity. Most fungal
pathogens are classiﬁed as opportunistic. This concept implies that under normal conditions, these
organisms are not capable of producing infection but, when host defenses are weakened, there
is room for them to prosper and to generate a health problem. Another general characteristic of
fungal infections is that they are frequently moderated and localized. However, fungal pathogens
are able to produce fungal disease, systemic infection, and even death in the worst scenarios.
In the last century, fungal infection cases have dramatically increased, especially in developed
countries. One work has shown that the number of cases of sepsis produced by fungal organisms
in the USA has increased by 207% between 1979 and 2000 (Martin et al., 2003). This phenomenon
is associated with the appearance of medical techniques, such as the use of broad-spectrum
antibiotics, the use of intravenous catheters, how intensive care units are organized, increased
number of organ transplants, or the development of cytotoxic chemotherapies. On top of that,
pandemics like HIV/AIDS have exponentially increased the number of patients with impaired
immunity. In fact, fungal disease was extremely rare before all these changes occurred.
A paradigm of an emerging fungal organism is the yeast Saccharomyces cerevisiae. This species
can be found naturally in many niches in the environment, but is most commonly known for its
Frontiers in Microbiology | www.frontiersin.org 1 January 2016 | Volume 6 | Article 1522
Pérez-Torrado and Querol Opportunistic Strains of Saccharomyces cerevisiae
role as “baker’s yeast” in either traditional or industrial
fermentative production of bread, beer or wine. It has also
been used as an agent to treat antibiotic-related diarrhea
and as a nutritional supplement, when it is commercialized
as S. boulardii. Classically, S. cerevisiae has been considered
a safe non pathogenic organism. However in the last two
decades, the number of cases of diagnosed infections has
increased, probably as a result of the increased numbers of
immunocompromised patients, but also due to advances made
in diagnostic methodologies in hospitals, including genetic
identiﬁcation by molecular techniques. S. cerevisiae has been
related to a wide variety of infections, which range from
vaginitis in healthy patients and cutaneous infections, to systemic
bloodstream infections and infections of essential organs
in immunocompromised and critically ill patients (Enache-
Angoulvant and Hennequin, 2005; Muñoz et al., 2005; de Llanos
et al., 2011). Infected patients tend to be elderly people, premature
children or patients suﬀering from immunosuppression due
to HIV/AIDS, treatment with immunosuppressive agents, or
other conditions associated with a deﬁcient immune response.
Furthermore, severe infections with S. cerevisiae have been
occasionally reported in patients with no obvious predisposing
factors (Jensen and Smith, 1976; Smith et al., 2002). All these data
have changed the status of S. cerevisiae, which is now considered
an emerging opportunistic pathogen (Herbrecht and Nivoix,
2005; de Llanos et al., 2006).
S. cerevisiae POPULATION DIVERSITY:
OPPORTUNISTIC STRAINS
The species S. cerevisiae is very heterogeneous and contains
strains with speciﬁc abilities like sherry wine strains, S. boulardii
or baker strains. Before the development of high throughput
sequencing techniques, the population structure of S. cerevisiae
was not very clear. Now we know that it is structured into several
genetically pure subpopulations and many mosaic strains that
contain gene alleles of diﬀerent subpopulations (Liti et al., 2009).
In the last decade, yeast scientists have attempted to determine
if the strains isolated from infected patients form a speciﬁc
S. cerevisiae subpopulation with any special characteristic. de
Llanos et al. (2004) used molecular markers as mt DNA
restriction patterns and showed that clinical strains were present
in several genetically diﬀerentiated groups of strains. In contrast,
Carreto et al. (2008) used comparative genome hybridization
on array (aCGH), and suggested that clinical strains could be a
genetically homogenous subpopulation. Later, Wei et al. (2007)
sequenced the genome of S. cerevisiae strain YJM789 derived
from a yeast isolated from the lung of an AIDS patient with
pneumonia. Liti et al. (2009) sequenced 36 new strains that
contained six clinical isolates. Strope et al. (2015) sequenced
93 strains from multiple geographic and environmental origins,
including several clinical strains. Finally, after the sequencing of
the whole genome of several clinical strains, it turns out that they
are not a genetically homogenous group of strains, but are all
mosaic strains with relatively heterogeneous genetic content (Liti
et al., 2009; Strope et al., 2015).
Several studies have analyzed the potential virulence of this
yeast species in vitro (McCusker et al., 1994; de Llanos et al.,
2006) and in vivo (McCullough et al., 1998; de Llanos et al.,
2011), and have suggested that some strains have the potential
to cause disease regardless of their clinical or non clinical
isolation origin. Many strains of S. cerevisiae, which have been
isolated in clinical settings, present very low levels of virulence
in mice infection models, while other strains, such as strain
D14 isolated from a dietetic supplement, have shown a relative
high level of virulence in diﬀerent infection models (Llopis
et al., 2012, 2014; Pérez-Torrado et al., 2015). Thus we propose
that the term “opportunistic strain” is used more accurately
and usefully to categorize these strains rather than “clinical
strains” since not all clinical strains cause infections. Even more
importantly, some non clinical strains can cause infections. We
deﬁne opportunistic S. cerevisiae strains as those strains which
show physiologic characteristics of yeast pathogens, such as
growth, at 37 ◦C (McCusker et al., 1994; de Llanos et al., 2006),
but unlike most other strains, can also cause infections and kill
mice (de Llanos et al., 2011). These strains also survive better
in human blood infection models than other strains, which
may enable them to disseminate across the body and reach
organs under adequate propagation conditions and in certain
circumstances (Lin et al., 2012). Increased blood survival can be a
key feature to distinguish these opportunistic yeasts strains from
others.
S. cerevisiae INFECTION MECHANISMS
The infection mechanism of C. albicans, a fungal pathogen that
is phylogenetically close to S. cerevisiae, is based on a ﬁrst step of
adhesion to human surface tissues and uses a family of proteins
called adhesins. C. albicans is also able to penetrate epithelial or
endothelial barriers via active mechanisms (Dalle et al., 2010).
A second important aspect of infection mechanisms is resistance
to the stressful situations generated after an encounter with cells
of the immune system. In contrast, S. cerevisiae lacks homologous
genes for the well-known C. glabrata or C. albicans adhesins
and shows low adhesion levels to human tissues compared to
both Candida species (Pérez-Torrado et al., 2012). It has been
suggested that S. cerevisiae can only perform opportunistic or
passive crossings when epithelial barrier integrity is previously
compromised (Pérez-Torrado et al., 2012).
However, previous studies by our group (Llopis et al., 2012)
have demonstrated that opportunistic S. cerevisiae strains show a
speciﬁc transcription pattern after human blood infection, which
reﬂects a speciﬁc oxidative stress response, increased amino acid
biosynthesis and a DNA damage repair response (Figure 1).
Yeast pathogens are adapted to resist human defenses and
one of the main responses of the immune system is microbe
engulfment and oxidative burst. Neutrophils, macrophages and
other cells with phagocytic capacity generate potent reactive
oxygen and nitrogen species (ROS and RNS), which can be
lethal to most fungal pathogens by causing damage to DNA,
proteins and lipids (Bogdan et al., 2000). Most fungal pathogens
display resistance to the reactive oxygen and nitrogen species
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FIGURE 1 | Molecular mechanisms of persistence of Saccharomyces
cerevisiae cells after neutrophil engulfment. Opportunistic S. cerevisiae
strains redirect the low levels of the nitrogen sources inside the phagosome to
increase amino acids (aa’s) biosynthesis. These strains also increase the
oxidative stress response by activating the Yap1p transcription factor regulon
to counteract the lethal effects of reactive oxygen species (ROS) generated by
the macrophage. De novo dNTP biosynthesis is activated to allow DNA repair
machinery to counteract ROS-induced mutations.
used by human cells to counteract infection (Brown et al., 2009).
Fungal resistance to ROS oﬀers protection from oxidative host
defenses and is undoubtedly an advantageous pathobiological
property (Lushchak et al., 2010; Rodrigues-Pousada et al., 2010).
It has been described that pathogens such as C. albicans
or C. neoformans have the potential to resist, among other
suboptimal conditions, oxidative stress produced by the ROS
generated in the phagosome (Brown et al., 2007, 2014). Indeed
the thioredoxin system of C. albicans and S. cerevisiae has
been shown to be expressed during growth in human blood or
mucosal tissue (Fradin et al., 2003, 2005, Zakikhany et al., 2007;
Llopis et al., 2012), which indicates that the ability to respond
to oxidative stress might be crucial in early stages of systemic
infections. TRX1 (thioredoxin 1) is also necessary to survive the
oxidative environment of macrophages in C. neoformans, and is
important for the virulence of this fungal pathogen (Missall and
Lodge, 2005). The TSA2 (thioredoxin peroxidase 2) and GPX2
(glutathione peroxidase 2) genes have been shown to be induced
in S. cerevisiae strains when exposed to neutrophils (Rubin-
Bejerano et al., 2003), and a clear antioxidant response has been
observed. Fradin et al. (2005) demonstrated that neutrophils
play a key role in bloodstream infections with C. albicans.
This observation is in line with the high susceptibility shown
by neutropenic patients (deﬁcient in these immune cells) to
disseminated candidiasis (Bodey et al., 1992; Wright andWenzel,
1997). In S. cerevisiae, the main role of proper oxidative stress
response virulence has been suggested since a virulent strain
mutant in transcription factor Yap1p, the main transcription
factor involved in oxidative stress response that is unable to
grow under oxidative stress conditions, presented low survival
levels in human blood compared with the wild type or the YAP1
reconstituted strain (Llopis et al., 2012). Diezmann and Dietrich
(2011) compared hundreds of clinical isolates and showed that
they were more resistant to oxidative stress after they veriﬁed the
central role of oxidative stress resistance in S. cerevisiae virulence.
After exposure to human neutrophils or cultured
macrophages, C. albicans cells up-regulate amino acid
biosynthetic genes (Rubin-Bejerano et al., 2003; Fradin et al.,
2005). Rubin-Bejerano et al. (2003) observed induction for these
pathways after C. albicans and S. cerevisiae cells were ingested
by neutrophils. This suggests that the microenvironment in the
phagosome inside the neutrophil is deﬁcient in amino acids, and
generates a rapid response from yeast strains. The methionine
and arginine biosynthetic genes are induced when S. cerevisiae
is phagocytized by the murine macrophage-like cell line (Lorenz
and Fink, 2001). Kingsbury et al. (2006) revealed the relevance
of amino acid biosynthesis for yeast survival in a murine host
and suggested that yeast can use a variety of nitrogen sources
under these conditions. The glyoxylate cycle is also induced
upon phagocytes ingestion of the bacterium Mycobacterium
tuberculosis (McKinney et al., 2000), and other fungi such as
C. neoformans (Rude et al., 2002), Leptosphaeria maculans
(Idnurm and Howlett, 2002), C. albicans (Lorenz and Fink,
2001), and S. cerevisiae (Lorenz and Fink, 2001). This change
in metabolism is a response to the glucose-poor environment
of the macrophage, and contributes to the virulence of some
pathogens. The ICL1 gene, which encodes for isocitrate lyase,
one of the principal enzymes of the glyoxylate cycle, has been
recently shown to be substantially induced upon exposure to
macrophages in vitro in both S. cerevisiae and C. albicans (Lorenz
and Fink, 2001; Lorenz et al., 2004). All these data suggest that
the ICL1 gene may also play a general role in S. cerevisiae in
human infections.
A common mechanism described for human microbial
pathogens is to increase dNTP pools in order to repair the
DNA damage caused by the oxidative burst of phagocytes.
The importance of a de novo nucleotide biosynthetic pathway
for phagocyte survival has been demonstrated for bacterial
pathogens such as Salmonella enterica (Panosa et al., 2010),
Bacteroides fragilis (Smalley et al., 2002), Pseudomonas
aeruginosa (Sjöberg and Torrents, 2011), Staphylococcus
aureus (Kirdis et al., 2007), Streptococcus pyogenes (Le
Breton et al., 2013), Bacillus anthracis, and Escherichia coli
(Samant et al., 2008). The relevance of de novo nucleotide
biosynthetic pathways has also been implicated for fungal
pathogens like Cryptococcus neoformans (Morrow et al.,
2012) or C. albicans (Donovan et al., 2001; Jiang et al., 2010),
and nucleotide biosynthetic pathways have been discussed
as a target for antifungal compounds (Rodriguez-Suarez
et al., 2007). In a recent study, we observed that S. cerevisiae
opportunistic strains, like other human pathogens, have the
enhanced ability to produce dNTPs, the substrates used by
DNA repair machineries (Pérez-Torrado et al., 2015). The
importance of this pathway for the virulence of S. cerevisiae
has been conﬁrmed by experimental infections conducted in
immunodeﬁcient murine models using a gua1 mutant, which
is a key enzyme for de novo dNTP biosynthesis. Additions of
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exogenous guanine and the use of mutants in the DNA damage
checkpoint, which activates dNTP biosynthesis in yeast cells,
aﬀects the survival of yeast cells in ex vivo blood infections (Pérez-
Torrado et al., 2015). The nitrogen source preferentially used by
yeasts in phagosomes to increase this pathway is still unknown.
CONCLUSION AND PERSPECTIVES
In developed countries, consumers have been driven to take
a more critical attitude about what they eat and drink
as a requirement of modern life. Food microbiologists are
facing the huge challenge of regarding food freshness that
is implicit in consumer demand for more natural products.
Additive-free safer food with less severe processing that has a
satisfactory shelf life and is easy to prepare is required given
the greater awareness of nutrition and health. These changes
in consumer preferences, which modify food processes, may
have important consequences and could aﬀect both food quality
and safety. Yeasts, especially S. cerevisiae, have an impeccably
good food safety record compared to other microorganisms
like virus, bacteria and some ﬁlamentous fungi. However,
humans unknowingly and inadvertently ingest large, viable
populations of S. cerevisiae without them having adverse impacts
on their health (e.g., yeasts in home-brewed beer, beers enriched
by yeast or dietary supplements that contain yeast are very
common today). Nevertheless, having an open mind about,
and conducting vigilance of, yeasts and food-borne diseases
are required. Compared with other microbial groups, yeasts
are not seen as aggressive pathogens, but they are capable of
causing human disease in opportunistic circumstances (Puig-
Asensio et al., 2014). As we summarize in this paper, yeast
researchers have made progress in understanding the nature
and virulence mechanism in S. cerevisiae strains. In the
future, more attention has to be paid to industrial practices
that are more prone to generate opportunistic S. cerevisiae
strains.
ACKNOWLEDGMENTS
RP-T was supported by CICYT grants (ref. AGL2012-39937-
CO2-01 and -02) from the Spanish Ministry of Education
and Science and FEDER. This work was supported by
grant PROMETEO (project PROMETEO/2009/019) from the
Generalitat Valenciana.
REFERENCES
Bodey, G., Bueltmann, B., Duguid, W., Gibbs, D., Hanak, H., Hotchi, M.,
et al. (1992). Fungal infections in cancer patients: an international autopsy
survey. Eur. J. Clin. Microbiol. Infect. Dis. 11, 99–109. doi: 10.1007/BF0196
7060
Bogdan, C., Rollinghoﬀ, M., and Diefenbach, A. (2000). Reactive oxygen and
reactive nitrogen intermediates in innate and speciﬁc immunity. Curr. Opin.
Immunol. 12, 64–76. doi: 10.1016/S0952-7915(99)00052-7
Brown, A. J., Budge, S., Kaloriti, D., Tillmann, A., Jacobsen, M. D., Yin, Z., et al.
(2014). Stress adaptation in a pathogenic fungus. J. Exp. Biol. 217, 144–155. doi:
10.1242/jeb.088930
Brown, A. J., Haynes, K., and Quinn, J. (2009). Nitrosative and oxidative stress
responses in fungal pathogenicity. Curr. Opin. Microbiol. 12, 384–391. doi:
10.1016/j.mib.2009.06.007
Brown, S. M., Campbell, L. T., and Lodge, J. K. (2007). Cryptococcus
neoformans, a fungus under stress. Curr. Opin. Microbiol. 10, 320–325. doi:
10.1016/j.mib.2007.05.014
Carreto, L., Eiriz, M. F., Gomes, A. C., Pereira, P. M., Schuller, D., and Santos,
M. A. (2008). Comparative genomics of wild type yeast strains unveils
important genome diversity. BMC Genomics 9:524. doi: 10.1186/1471-216
4-9-524
Dalle, F., Wachtler, B., L’Ollivier, C., Holland, G., Bannert, N., Wilson, D.,
et al. (2010). Cellular interactions of Candida albicans with human oral
epithelial cells and enterocytes.Cel. Microbiol. 12, 248–271. doi: 10.1111/j.1462-
5822.2009.01394.x
de Llanos, R., Fernandez-Espinar, M. T., and Querol, A. (2006). A comparison
of clinical and food Saccharomyces cerevisiae isolates on the basis of potential
virulence factors. Antonie Van Leeuwenhoek 90, 221–231. doi: 10.1007/s10482-
006-9077-7
de Llanos, R., Llopis, S., Molero, G., Querol, A., Gi, C., and Fernandez-Espinar,
M. T. (2011). In vivo virulence of commercial Saccharomyces cerevisiae strains
with pathogenicity-associated phenotypical traits. Int. J. Food. Microbiol. 144,
393–399. doi: 10.1016/j.ijfoodmicro.2010.10.025
de Llanos, R., Querol, A., Planes, A. M., and Fernández-Espinar, M. T. (2004).
Molecular characterization of clinical Saccharomyces cerevisiae isolates and
their association with non-clinical strains. Syst. Appl. Microbiol. 27, 427–435.
doi: 10.1078/0723202041438473
Diezmann, S., and Dietrich, F. S. (2011). Oxidative stress survival in a clinical
Saccharomyces cerevisiae isolate is inﬂuenced by a major quantitative trait
nucleotide. Genetics 188, 709–722. doi: 10.1534/genetics.111.128256
Donovan, M., Schumuke, J. J., Fonzi, W. A., Bonar, S. L., Gheesling-Mullis, K.,
Jacob, G. S., et al. (2001). Virulence of a phosphoribosyl aminoimidazole
carboxylase-deﬁcient Candida albicans strain in an immunosuppressed
murine model of systemic candidiasis. Infect. Immun. 69, 2542–2548. doi:
10.1128/IAI.69.4.2542-2548.2001
Enache-Angoulvant, A., and Hennequin, C. (2005). Invasive Saccharomyces
infection: a comprehensive review. Clin. Infect. Dis. 41, 1559–1568. doi:
10.1086/497832
Fradin, C., De Groot, P., MacCallum, D., Schaller, M., Klis, F., Odds, F. C., et al.
(2005). Granulocytes govern the transcriptional response, morphology and
proliferation of Candida albicans in human blood.Mol. Microbiol. 56, 397–415.
doi: 10.1111/j.1365-2958.2005.04557.x
Fradin, C., Kretschmar, M., Nichterlein, T., Gaillardin, C., d’Enfert, C., and
Hube, B. (2003). Stage-speciﬁc gene expression of Candida albicans in
human blood. Mol. Microbiol. 47, 1523–1543. doi: 10.1046/j.1365-2958.2003.
03396.x
Herbrecht, R., and Nivoix, Y. (2005). Saccharomyces cerevisiae fungemia: an
adverse eﬀect of Saccharomyces boulardii probiotic administration. Clin. Infect.
Dis. 40, 1635–1637. doi: 10.1086/429926
Idnurm, A., and Howlett, B. J. (2002). Isocitrate lyase is essential for pathogenicity
of the fungus Leptosphaeria maculans to canola (Brassica napus). Eukaryot. Cell
1, 719–724. doi: 10.1128/EC.1.5.719-724.2002
Jensen, D. P., and Smith, D. L. (1976). Fever of unknown origin secondary
to brewer’s yeast ingestion. Arch. Intern. Med. 136, 332–333. doi:
10.1001/archinte.1976.03630030064011
Jiang, L., Zhao, J., Guo, R., Li, J., Yu, L., and Xu, D. (2010). Functional
characterization and virulence study of ADE8 and GUA1 genes involved in the
de novo purine biosynthesis in Candida albicans. FEMS Yeast Res. 10, 199–208.
doi: 10.1111/j.1567-1364.2009.00600.x
Kingsbury, J. M., Goldstein, A. L., and McCusker, J. H. (2006). Role of nitrogen
and carbon transport, regulation, and metabolism genes for Saccharomyces
cerevisiae survival in vivo. Eukaryot. Cell 5, 816–824. doi: 10.1128/EC.5.5.816-
824.2006
Kirdis, E., Jonsson, I. M., Kubica, M., Potempa, J., Josefsson, E., and Masalha, M.
(2007). Ribonucleotide reductase class III, an essential enzyme for the anaerobic
Frontiers in Microbiology | www.frontiersin.org 4 January 2016 | Volume 6 | Article 1522
Pérez-Torrado and Querol Opportunistic Strains of Saccharomyces cerevisiae
growth of Staphylococcus aureus, is a virulence determinant in septic arthritis.
Microb. Pathog. 3, 179–188. doi: 10.1016/j.micpath.2007.05.008
Le Breton, Y., Mistry, P., Valdes, K. M., Quigley, J., Kumar, N., Tettelin, H.,
et al. (2013). Genome-wide identiﬁcation of genes required for ﬁtness of
group a Streptococcus in human blood. Infect. Immun. 81, 862–875. doi:
10.1128/IAI.00837-12
Lin, L., Ibrahim, A. S., Baquir, B., Palosaari, A., and Spellberg, B. (2012).
Luminescent-activated transfected killer cells to monitor leukocyte traﬃcking
during systemic bacterial and fungal infection. J. Infect. Dis. 205, 337–347. doi:
10.1093/infdis/jir72522124127
Liti, G., Carter, D. M., Moses, A. M., Warringer, J., Parts, L., James, S. A., et al.
(2009). Population genomics of domestic and wild yeasts. Nature 458, 337–341.
doi: 10.1038/nature07743
Llopis, S., Hernández-Haro, C., Monteoliva, L., Querol, A., Molina, M., and
Fernández-Espinar, M. T. (2014). Pathogenic potential of Saccharomyces
strains isolated from dietary supplements. PLoS ONE 9:e98094. doi:
10.1371/journal.pone.0098094
Llopis, S., Querol, A., Heyken, A., Hube, B., Jespersen, L., Fernandez-Espinar, T.,
et al. (2012). Transcriptomics in human blood incubation reveals the
importance of oxidative stress response in Saccharomyces cerevisiae clinical
strains. BMC Genomics 13:419. doi: 10.1186/1471-2164-13-419
Lorenz, M. C., Bender, J. A., and Fink, G. R. (2004). Transcriptional response
of Candida albicans upon internalization by macrophages. Eukaryot. Cell 3,
1076–1087. doi: 10.1128/EC.3.5.1076-1087.2004
Lorenz, M. C., and Fink, G. R. (2001). The glyoxylate cycle is required for fungal
virulence. Nature 412, 83–86. doi: 10.1038/35083594
Lushchak, O. V., Inoue, Y., and Lushchak, V. I. (2010). Regulatory protein Yap1
is involved in response of yeast Saccharomyces cerevisiae to nitrosative
stress. Biochemistry (Mosc.) 75, 629–664. doi: 10.1134/S00062979100
50135
Martin, G. S., Mannino, D. M., Eaton, S., and Moss, M. (2003). The epidemiology
of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348,
1546–1554. doi: 10.1056/NEJMoa022139
McCullough, M. J., Clemons, K. V., McCusker, J. H., and Stevens, D. A. (1998).
Species identiﬁcation and virulence attributes of Saccharomyces boulardii (nom.
inval.). J. Clin. Microbiol. 36, 2613–2617.
McCusker, J. H., Clemons, K. V., Stevens, D. A., and Davis, R. W. (1994).
Saccharomyces cerevisiae virulence phenotype as determined with CD-1 mice
is associated with the ability to grow at 42 degrees C and form pseudohyphae.
Infect. Immun. 62, 5447–5455.
McKinney, J. D., Honerzu, B. K., Munoz-Elias, E. J., Miczak, A., Chen, B., Chan,
W. T., et al. (2000). Persistence ofMycobacterium tuberculosis in macrophages
and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406,
735–738. doi: 10.1038/35021074
Missall, T. A., and Lodge, J. K. (2005). Function of the thioredoxin proteins in
Cryptococcus neoformans during stress or virulence and regulation by putative
transcriptional modulators. Mol. Microbiol. 57, 847–858. doi: 10.1111/j.1365-
2958.2005.04735.x
Morrow, C. A., Valkov, E., Stamp, A., Chow, E. W., Lee, I. R., Wronski, A.,
et al. (2012). De novo GTP biosynthesis is critical for virulence of the
fungal pathogen Cryptococcus neoformans. PLoS Pathog. 8:e1002957. doi:
10.1371/journal.ppat.1002957
Muñoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-
Somolinos, M., et al. (2005). Saccharomyces cerevisiae fungemia: an emerging
infectious disease. Clin. Infect. Dis. 40, 1625–1634. doi: 10.1086/429916
Panosa, A., Roca, I., and Gibert, I. (2010). Ribonucleotide reductases of Salmonella
typhimurium transcriptional regulation and diﬀerential role in pathogenesis.
PLoS ONE 5:e11328. doi: 10.1371/journal.pone.0011328
Pérez-Torrado, R., Llopis, S., Jespersen, L., Fernández-Espinar, T., and
Querol, A. (2012). Clinical Saccharomyces cerevisiae isolates cannot cross
the epithelial barrier in vitro. Int. J. Food Microbiol. 157, 59–64. doi:
10.1016/j.ijfoodmicro.2012.04.012
Pérez-Torrado, R., Llopis, S., Perrone, B., Gómez-Pastor, R., Hube, B., and
Querol, A. (2015). Comparative genomic analysis reveals a critical role of de
novo nucleotide biosynthesis for Saccharomyces cerevisiae virulence. PLoS ONE
10:e0122382. doi: 10.1371/journal.pone.0122382
Pfaller, M. A., and Diekema, D. J. (2007). Epidemiology of invasive candidiasis:
a persistent public health problem. Clin. Microbiol. Rev. 20, 133–163. doi:
10.1128/CMR.00029-06
Puig-Asensio, M., Padilla, B., Garnacho-Montero, J., Zaragoza, O., Aguado, J. M.,
Zaragoza, R., et al. (2014). Epidemiology and predictive factors for early and late
mortality in Candida bloodstream infections: a population-based surveillance in
Spain. Clin. Microbiol. Infect. 20, O245–O254. doi: 10.1111/1469-0691.12380
Rodrigues-Pousada, C., Menezes, R. A., and Pimentel, C. (2010). The Yap family
and its role in stress response. Yeast 27, 245–258. doi: 10.1002/yea.1752
Rodriguez-Suarez, R., Xu, D., Veillette, K., Davison, J., Sillaots, S., Kauﬀman, S.,
et al. (2007). Mechanism-of-action determination of GMP synthase inhibitors
and target validation in Candida albicans and Aspergillus fumigatus. Chem. Biol.
14, 1163–1175. doi: 10.1016/j.chembiol.2007.09.009
Rubin-Bejerano, I., Fraser, I., Grisaﬁ, P., and Fink, G. R. (2003). Phagocytosis
by neutrophils induces an amino acid deprivation response in Saccharomyces
cerevisiae and Candida albicans. Proc. Natl. Acad. Sci. U.S.A. 100, 11007–11012.
doi: 10.1073/pnas.1834481100
Rude, T. H., Toﬀaletti, D. L., Cox, G. M., and Perfect, J. R. (2002). Relationship of
the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans. Infect.
Immun. 70, 5684–5694. doi: 10.1128/IAI.70.10.5684-5694.2002
Samant, S., Lee, H., Ghassemi, M., Chen, J., Cook, J. L., Mankin, A. S., et al. (2008).
Nucleotide biosynthesis is critical for growth of bacteria in human blood. PLoS
Pathog. 4:e37. doi: 10.1371/journal.ppat.0040037
Sjöberg, B. M., and Torrents, E. (2011). Shift in ribonucleotide reductase gene
expression in Pseudomonas aeruginosa during infection. Infect. Immun. 79,
2663–2669. doi: 10.1128/IAI.01212-10
Smalley, D., Rocha, E. R., and Smith, C. J. (2002). Aerobic-type ribonucleotide
reductase in the anaerobe Bacteroides fragilis. J. Bacteriol. 184, 895–903. doi:
10.1128/jb.184.4.895-903.2002
Smith, D., Metzgar, D., Wills, C., and Fierer, J. (2002). Fatal Saccharomyces
cerevisiae aortic graft infection. J. Clin. Microbiol. 40, 2691–2692. doi:
10.1128/JCM.40.7.2691-2692.2002
Strope, P. K., Skelly, D. A., Kozmin, S. G., Mahadevan, G., Stone, E. A., Magwene,
P. M., et al. (2015). The 100-genomes strains, an S. cerevisiae resource that
illuminates its natural phenotypic and genotypic variation and emergence as an
opportunistic pathogen. Genome Res. 25, 762–774. doi: 10.1101/gr.185538.114
Wei, W., McCusker, J. H., Hyman, R. W., Jones, T., Ning, Y., Cao, Z.,
et al. (2007). Genome sequencing and comparative analysis of Saccharomyces
cerevisiae strain YJM789. Proc. Natl. Acad. Sci. U.S.A. 104, 12825–12830. doi:
10.1073/pnas.0701291104
Wright, W. L., and Wenzel, R. P. (1997). Nosocomial candida epidemiology,
transmission, and prevention. Infect. Dis. Clin. North. Am. 11, 411–425. doi:
10.1016/S0891-5520(05)70363-9
Zakikhany, K., Naglik, J. R., Schmidt-Westhausen, A., Holland, G., Schaller, M.,
and Hube, B. (2007). In vivo transcript proﬁling of Candida albicans identiﬁes
a gene essential for interepithelial dissemination. Cell. Microbiol. 9, 2938–2954.
doi: 10.1111/j.1462-5822.2007.01009.x
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or ﬁnancial relationships that could
be construed as a potential conﬂict of interest.
Copyright © 2016 Pérez-Torrado and Querol. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 5 January 2016 | Volume 6 | Article 1522
